Hoffman Michael B
Insider CIK 1290208 · ONTX Director, 10% owner · ANVS Director, 10% owner · TDAC Chairman and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TDAC Translational Development | P Buy deriv | 2026-05-27 | 2026-05-29 | 53,395 | $0.79 | $42.2K | 53,395 | SEC↗ |
| ANVS Annovis Bio, Inc. | P Buy | 2026-05-20 | 2026-05-21 | 18,849 | $1.80 | $33.9K | 3,309,950 | SEC↗ |
| ANVS Annovis Bio, Inc. | P Buy | 2026-05-20 | 2026-05-21 | 2,562 | $1.75 | $4.5K | 3,291,101 | SEC↗ |
| ANVS Annovis Bio, Inc. | P Buy | 2026-05-20 | 2026-05-21 | 54,933 | $1.90 | $104.4K | 3,364,883 | SEC↗ |
| ANVS Annovis Bio, Inc. | P Buy | 2026-04-02 | 2026-04-03 | 713,800 | $2.10 | $1.50M | 3,288,539 | SEC↗ |
| ANVS Annovis Bio, Inc. | P Buy | 2025-12-08 | 2025-12-08 | 30,000 | $4.34 | $130.2K | 2,559,739 | SEC↗ |
| ANVS Annovis Bio, Inc. | P Buy | 2025-12-08 | 2025-12-08 | 15,000 | $4.24 | $63.6K | 2,574,739 | SEC↗ |
| ANVS Annovis Bio, Inc. | P Buy | 2025-11-24 | 2025-11-25 | 1,489 | $4.13 | $6.1K | 2,482,028 | SEC↗ |
| ANVS Annovis Bio, Inc. | P Buy | 2025-11-24 | 2025-11-25 | 9,200 | $3.85 | $35.4K | 2,491,228 | SEC↗ |
| ANVS Annovis Bio, Inc. | P Buy | 2025-11-24 | 2025-11-25 | 415 | $4.14 | $1.7K | 2,491,643 | SEC↗ |
| ANVS Annovis Bio, Inc. | P Buy | 2025-11-24 | 2025-11-25 | 28,096 | $4.15 | $116.6K | 2,519,739 | SEC↗ |
| ANVS Annovis Bio, Inc. | P Buy | 2025-11-24 | 2025-11-25 | 9,200 | $3.85 | $35.4K | 2,501,228 | SEC↗ |
| ANVS Annovis Bio, Inc. | P Buy | 2025-11-24 | 2025-11-25 | 415 | $4.14 | $1.7K | 2,501,643 | SEC↗ |
| ANVS Annovis Bio, Inc. | P Buy | 2025-11-24 | 2025-11-25 | 28,096 | $4.15 | $116.6K | 2,529,739 | SEC↗ |
| ANVS Annovis Bio, Inc. | P Buy | 2025-11-24 | 2025-11-25 | 1,489 | $4.13 | $6.1K | 2,492,028 | SEC↗ |
| ANVS Annovis Bio, Inc. | P Buy | 2025-11-21 | 2025-11-21 | 10,000 | $3.50 | $35.0K | 2,490,539 | SEC↗ |
| ANVS Annovis Bio, Inc. | P Buy | 2025-11-21 | 2025-11-21 | 10,000 | $3.49 | $34.9K | 2,480,539 | SEC↗ |
| ANVS Annovis Bio, Inc. | P Buy | 2025-11-14 | 2025-11-18 | 15,000 | $2.11 | $31.6K | 2,470,539 | SEC↗ |
| ANVS Annovis Bio, Inc. | P Buy | 2025-10-28 | 2025-11-12 | 975,610 | $2.05 | $2.00M | 2,455,539 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award | 2025-08-29 | 2025-09-03 | 5,000 | $2.28 | $11.4K | 1,469,929 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award | 2025-08-29 | 2025-09-03 | 5,000 | $2.29 | $11.4K | 1,474,929 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award | 2025-08-29 | 2025-09-03 | 5,000 | $2.30 | $11.5K | 1,479,929 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award | 2025-08-19 | 2025-08-20 | 1,100 | $2.57 | $2.8K | 1,464,929 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award | 2025-08-19 | 2025-08-20 | 6,717 | $2.60 | $17.5K | 1,453,001 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award | 2025-08-19 | 2025-08-20 | 5,283 | $2.59 | $13.7K | 1,458,284 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award | 2025-08-19 | 2025-08-20 | 5,545 | $2.58 | $14.3K | 1,463,829 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award | 2025-06-13 | 2025-06-16 | 25,000 | $2.80 | $70.0K | 1,446,283 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award | 2025-06-13 | 2025-06-16 | 1 | $2.83 | $3 | 1,446,284 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award | 2025-05-29 | 2025-06-02 | 5,000 | $2.43 | $12.2K | 1,421,283 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award | 2023-11-20 | 2023-11-21 | 164,745 | $6.07 | $1.00M | 224,222 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award | 2023-11-20 | 2023-11-22 | 163,880 | $6.10 | $999.7K | 223,357 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award deriv | 2023-11-17 | 2024-07-03 | 29,600 | — | $0 | 29,600 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award | 2023-04-07 | 2023-04-11 | 59,477 | $12.61 | $750.0K | 59,477 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award deriv | 2023-01-18 | 2023-01-20 | 6,820 | — | $0 | 6,820 | SEC↗ |
| ANVS Annovis Bio, Inc. | M Exercise deriv | 2022-01-04 | 2022-01-05 | 7,142 | — | $0 | 0 | SEC↗ |
| ANVS Annovis Bio, Inc. | M Exercise deriv | 2022-01-04 | 2022-01-05 | 30,000 | — | $0 | 0 | SEC↗ |
| ANVS Annovis Bio, Inc. | M Exercise | 2022-01-04 | 2022-01-05 | 30,000 | $4.39 | $131.7K | 1,415,889 | SEC↗ |
| ANVS Annovis Bio, Inc. | F Tax w/h | 2022-01-04 | 2022-01-05 | 6,658 | $19.78 | $131.7K | 1,409,231 | SEC↗ |
| ANVS Annovis Bio, Inc. | M Exercise | 2022-01-04 | 2022-01-05 | 7,142 | $0.25 | $1.8K | 1,416,373 | SEC↗ |
| ANVS Annovis Bio, Inc. | F Tax w/h | 2022-01-04 | 2022-01-05 | 90 | $19.78 | $1.8K | 1,416,283 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 9,000 | — | $0 | 9,000 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award deriv | 2021-07-07 | 2021-07-09 | 4,500 | — | $0 | 4,500 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | S Sale | 2020-08-27 | 2020-08-31 | 1,876 | $0.27 | $507 | 0 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | S Sale | 2020-08-27 | 2020-08-31 | 182,492 | $0.27 | $49.3K | 21,919 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | A Award deriv | 2020-07-09 | 2020-07-10 | 125,000 | — | $0 | 125,000 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award deriv | 2020-07-01 | 2020-07-06 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ANVS Annovis Bio, Inc. | C Conversion deriv | 2020-01-31 | 2020-02-05 | 1,593,118 | — | $0 | 0 | SEC↗ |
| ANVS Annovis Bio, Inc. | C Conversion deriv | 2020-01-31 | 2020-02-05 | 55,884 | $4.80 | $268.2K | 0 | SEC↗ |
| ANVS Annovis Bio, Inc. | C Conversion deriv | 2020-01-31 | 2020-02-05 | 222,222 | — | $0 | 0 | SEC↗ |
| ANVS Annovis Bio, Inc. | P Buy | 2020-01-31 | 2020-02-05 | 33,333 | $6.00 | $200.0K | 47,619 | SEC↗ |
| ANVS Annovis Bio, Inc. | C Conversion | 2020-01-31 | 2020-02-05 | 158,730 | — | $0 | 206,349 | SEC↗ |
| ANVS Annovis Bio, Inc. | C Conversion | 2020-01-31 | 2020-02-05 | 1,137,942 | — | $0 | 1,344,291 | SEC↗ |
| ANVS Annovis Bio, Inc. | C Conversion | 2020-01-31 | 2020-02-05 | 55,884 | $4.80 | $268.2K | 1,400,175 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | A Award deriv | 2019-07-26 | 2019-07-29 | 5,833 | — | $0 | 5,833 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | S Sale | 2018-08-29 | 2018-08-29 | 29,999 | $0.45 | $13.5K | 5,731,117 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | S Sale | 2018-08-28 | 2018-08-29 | 30,000 | $0.46 | $13.8K | 5,761,116 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | S Sale | 2018-08-28 | 2018-08-29 | 20,000 | $0.44 | $8.8K | 5,791,116 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | S Sale | 2018-08-27 | 2018-08-29 | 20,000 | $0.45 | $9.0K | 5,811,116 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | A Award deriv | 2018-07-26 | 2018-07-30 | 87,500 | — | $0 | 87,500 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | P Buy deriv | 2018-04-27 | 2018-05-01 | 2,211,765 | — | $0 | 2,211,765 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | P Buy | 2018-04-27 | 2018-05-01 | 2,211,765 | — | $0 | 3,192,438 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | A Award deriv | 2017-06-12 | 2017-06-13 | 2,000 | — | $0 | 2,000 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | X Exercise deriv | 2016-07-29 | 2016-08-10 | 396,633 | — | $0 | 396,633 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | X Exercise | 2016-07-29 | 2016-08-10 | 528,845 | $4.10 | $2.17M | 980,673 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | X Exercise deriv | 2016-07-26 | 2016-08-10 | 528,845 | — | $0 | 0 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | A Award deriv | 2016-05-18 | 2016-05-20 | 13,000 | — | $0 | 13,000 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | A Award deriv | 2015-06-15 | 2015-06-17 | 13,000 | — | $0 | 13,000 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | M Exercise deriv | 2014-07-07 | 2014-07-09 | 18,754 | — | $0 | 0 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | M Exercise | 2014-07-07 | 2014-07-09 | 18,754 | $2.67 | $50.1K | 18,754 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | A Award deriv | 2014-05-22 | 2014-08-05 | 13,000 | — | $0 | 13,000 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | P Buy | 2014-02-21 | 2014-02-24 | 71,740 | $8.91 | $639.2K | 4,518,275 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | P Buy | 2014-02-20 | 2014-02-24 | 71,740 | $8.03 | $576.1K | 4,446,535 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | P Buy | 2014-01-27 | 2014-01-27 | 25,589 | $11.86 | $303.5K | 4,374,795 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | P Buy | 2014-01-24 | 2014-01-27 | 31,706 | $11.96 | $379.2K | 4,349,206 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | P Buy | 2013-11-22 | 2013-11-25 | 4,900 | $14.39 | $70.5K | 4,317,500 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | P Buy | 2013-11-22 | 2013-11-25 | 100 | $14.37 | $1.4K | 4,312,600 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | P Buy | 2013-11-18 | 2013-11-20 | 5,000 | $11.87 | $59.3K | 4,312,500 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | P Buy | 2013-11-15 | 2013-11-18 | 1,900 | $12.21 | $23.2K | 4,299,700 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | P Buy | 2013-11-15 | 2013-11-18 | 7,800 | $11.97 | $93.4K | 4,307,500 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | P Buy | 2013-11-15 | 2013-11-18 | 5,000 | $11.95 | $59.8K | 4,292,800 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | P Buy | 2013-11-15 | 2013-11-18 | 5,000 | $11.99 | $60.0K | 4,297,800 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion deriv | 2013-07-30 | 2013-08-01 | 1,635,514 | — | $0 | 0 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion deriv | 2013-07-30 | 2013-08-01 | 301,290 | — | $0 | 0 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion deriv | 2013-07-30 | 2013-08-01 | 229,825 | — | $0 | 0 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion deriv | 2013-07-30 | 2013-08-01 | 109,653 | — | $0 | 0 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion deriv | 2013-07-30 | 2013-08-01 | 111,227 | — | $0 | 109,653 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion deriv | 2013-07-30 | 2013-08-01 | 634,625 | — | $0 | 0 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion deriv | 2013-07-30 | 2013-08-01 | 99,350 | — | $0 | 0 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion deriv | 2013-07-30 | 2013-08-01 | 140,449 | — | $0 | 0 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion deriv | 2013-07-30 | 2013-08-01 | 355,528 | — | $0 | 0 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion | 2013-07-30 | 2013-08-01 | 84,530 | — | $0 | 1,746,953 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion | 2013-07-30 | 2013-08-01 | 83,857 | — | $0 | 728,517 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion | 2013-07-30 | 2013-08-01 | 1,226,942 | — | $0 | 3,372,330 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion | 2013-07-30 | 2013-08-01 | 226,024 | — | $0 | 2,145,388 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion | 2013-07-30 | 2013-08-01 | 172,411 | — | $0 | 1,919,364 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | P Buy | 2013-07-30 | 2013-08-01 | 1,000,000 | $15.00 | $15.00M | 4,372,330 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion | 2013-07-30 | 2013-08-01 | 85,744 | — | $0 | 1,662,423 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion | 2013-07-30 | 2013-08-01 | 476,087 | — | $0 | 1,576,679 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion | 2013-07-30 | 2013-08-01 | 266,712 | — | $0 | 1,100,592 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion | 2013-07-30 | 2013-08-01 | 105,363 | — | $0 | 833,880 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | A Award deriv | 2013-07-25 | 2013-07-29 | 13,000 | — | $0 | 13,000 | SEC↗ |